Æterna Zentaris

Companies Æterna Zentaris

News Æterna Zentaris

• Aeterna Zentaris Receives Positive Scientific Advice for its Phase 3 Trial with Perifosine in Colorectal Cancer

  Aeterna Zentaris Inc. announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer. The trial i more

• Aeterna Zentaris Reports Final Results of a Phase 2 Study of Perifosine in the Treatment of Colorectal Cancer

  Aeterna Zentaris Inc. reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, in combination with capecitabine (Xeloda(R)) as a treat more

• ElexoPharm Appoints Prof. Jürgen Engel as Chairman of the Advisory Board

  ElexoPharm GmbH announced the appointment of Professor Dr. Jürgen Engel as Chairman of its Advisory Board. He is going to support ElexoPharm’s efforts to expand its activities in preclinical drug development and to build up strong alliances with big pharmaceutical companies. As Chairman of the Advis more

Websites Æterna Zentaris